Table 1.
Demographic, clinical, and laboratory characteristics
| No NSAID (N= 64) | Received NSAID (N=146) | P value | |
|---|---|---|---|
| Age, years | 2.5 (0.35, 5.3) | 3.2 (0.8, 6.4) | 0.05 |
| Male | 61% (39) | 55% (80) | 0.41 |
| Caucasian | 84% (54) | 88% (129) | 0.43 |
| Bypass time, minutes | 95.5 (72.5, 165) | 83.5 (62, 116) | 0.02 |
| Hospital stay, days | 4 (3, 9.5) | 5 (4, 7) | 0.36 |
| Baseline Scr | 0.45 (0.4, 0.55) | 0.4 (0.4, 0.6) | 0.41 |
| % Scr change | 0 (0, 18.88) | 0 (0, 15) | 0.76 |
| History of prior bypass | 23% (15) | 42% (62) | 0.01 |
| RACHS-1 score | 0.01 | ||
| 1 | 9% (6) | 17% (25) | |
| 2 | 39% (25) | 45% (66) | |
| 3 | 34% (22) | 34% (50) | |
| 4 | 13% (8) | 3% (5) | |
| 5 | 3% (2) | 0% (0) | |
| 6 | 2% (1) | 0% (0) |
For continuous variables, median (interquartile range) are reported; for categorical variables, % (n) are reported. Scr, serum creatinine (mg/dl).